NCT06949228 - Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

May 30, 2028

Study Completion Date

May 30, 2028

Conditions

Ischemic StrokeAcute Disease

Interventions

DRUG

tenecteplase

Patients treated with standard of care mechanical thrombectomy (MT) that achieved mTICI 2b or higher revascularization. Patients will be randomized into one of two arms: IA TNK or control.

Trial Locations (1)

43606

RECRUITING

ProMedica Toledo Hospital, Toledo